DaVita HealthCare Partners Aktie
| 163,06USD | 1,69USD | 1,05% |
WKN: 897914 / ISIN: US23918K1088
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 95,53 |
| Berkshire Hathaway, Inc. | 44,02 |
| Berkshire Hathaway, Inc. (Investment Management) | 44,02 |
| The Vanguard Group, Inc. | 7,71 |
| Vanguard Group, Inc. (Subfiler) | 6,30 |
| State Street Corp. | 2,94 |
| Ted R Weschler | 2,66 |
| BlackRock Fund Advisors | 2,32 |
| Government Pension Fund - Global (The) | 1,91 |
| Vanguard Total Stock Market ETF | 1,63 |
| BlackRock Institutional Trust Co. NA | 1,49 |
| Vanguard 500 Index Fund | 1,47 |
| Geode Capital Management LLC | 1,42 |
| LSV Asset Management | 1,29 |
| Vanguard Small Cap Index Fund | 1,28 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 65 000 | 67 000 | 69 000 | 70 000 | 70 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,18 | 0,17 | 0,17 | 0,17 | 0,17 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 3 690 | 3 149 | 3 168 | 3 155 | 3 138 |
| Summe Anlagevermögen | 14 388 | 14 613 | 14 703 | 14 524 | 14 482 |
| Summe Aktiva | 18 078 | 17 762 | 17 871 | 17 680 | 17 619 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 11 176 | 11 194 | 11 975 | 11 822 | 11 116 |
| Summe Fremdkapital | 14 578 | 14 865 | 15 500 | 15 455 | 14 876 |
| Summe Eigenkapital | 3 500 | 2 897 | 2 371 | 2 225 | 2 743 |
| Summe Passiva | 18 078 | 17 762 | 17 871 | 17 680 | 17 619 |
Adresse
| 2000 16th Street, 80202-7198 Denver | |
| Telefon | +1 (720) 631-2100 |
| Internet | http://www.davita.com |
Management
|
Adam H. Schechter
Independent Director |
|
Alan Cullop
Chief Information Officer |
|
Andrew Mohraz
Associate General Counsel & Head-Investigations |
|
Barbara Jean Desoer
Independent Non-Executive Director |
|
Bruce E. Ware
Vice President |
|
Charles G. Berg
Independent Director |
|
Christopher M. Berry
Chief Accounting Officer |
|
David P. Maughan
Chief Operating Officer |
|
Dennis W. Pullin
Independent Director |
|
Gregory J. Moore
Independent Director |
|
James O. Hearty
Chief Compliance Officer |
|
Jason M. Hollar
Independent Director |
|
Javier J. Rodriguez
Chief Executive Officer & Director |
|
Jeffrey A. Giullian
Chief Medical Officer-Kidney Care |
|
Jeffrey Wagner
Senior Vice President |
|
Jessica Hergenreter
Chief People Officer |
|
Joel Ackerman
Chief Financial Officer & Treasurer |
|
Kathleen Alyce Waters
Chief Legal & Public Affairs Officer |
|
Madhu Narasimhan
Chief Information Officer |
|
Mahesh Krishnan
Group Vice President-Growth |
|
Michael D. Staffieri
Chief Operating Officer-Emeritus |
|
Nic Eliason
Investor Relations Contact |
|
Pamela M. Arway
Independent Chairman |
|
Phyllis R. Yale
Independent Non-Executive Director |
|
Samantha A. Caldwell
Secretary |
|
Wendy Lee Schoppert
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
